Lynne Powell Insider Trading for November 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Lynne Powell.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Lynne Powell for November 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 12,000 | 38,640 | 101,427 | |
Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.01 | 2,455 | 22,120 | 0 | 2.5 K to 0 (-100.00 %) |
Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 9.06 | 12,000 | 108,720 | 2,455 | 14.5 K to 2.5 K (-83.02 %) |
Nov 26 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 12,000 | 38,640 | 14,455 | 2.5 K to 14.5 K (+488.80 %) |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 9,127 | 29,389 | 113,427 | |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 9,127 | 29,389 | 113,427 | |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 193 | 621 | 122,554 | |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 193 | 621 | 122,554 | |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.61 | 6,150 | 52,952 | 2,455 | 8.6 K to 2.5 K (-71.47 %) |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.61 | 6,150 | 52,952 | 2,455 | 8.6 K to 2.5 K (-71.47 %) |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.52 | 9,127 | 77,762 | 8,605 | 17.7 K to 8.6 K (-51.47 %) |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.52 | 9,127 | 77,762 | 8,605 | 17.7 K to 8.6 K (-51.47 %) |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 9,127 | 29,389 | 17,732 | 8.6 K to 17.7 K (+106.07 %) |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 9,127 | 29,389 | 17,732 | 8.6 K to 17.7 K (+106.07 %) |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.30 | 193 | 1,602 | 8,605 | 8.8 K to 8.6 K (-2.19 %) |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.30 | 193 | 1,602 | 8,605 | 8.8 K to 8.6 K (-2.19 %) |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 193 | 621 | 8,798 | 8.6 K to 8.8 K (+2.24 %) |
Nov 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 193 | 621 | 8,798 | 8.6 K to 8.8 K (+2.24 %) |
Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 5,280 | 17,002 | 122,747 | |
Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 300 | 966 | 128,027 | |
Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.15 | 5,280 | 43,032 | 8,605 | 13.9 K to 8.6 K (-38.03 %) |
Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 5,280 | 17,002 | 13,885 | 8.6 K to 13.9 K (+61.36 %) |
Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.00 | 300 | 2,400 | 8,605 | 8.9 K to 8.6 K (-3.37 %) |
Nov 09 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 300 | 966 | 8,905 | 8.6 K to 8.9 K (+3.49 %) |
Nov 07 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 100 | 322 | 128,327 | |
Nov 07 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.00 | 100 | 800 | 8,605 | 8.7 K to 8.6 K (-1.15 %) |
Nov 07 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 100 | 322 | 8,705 | 8.6 K to 8.7 K (+1.16 %) |
Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Option Exercise | M | 3.22 | 1,000 | 3,220 | 128,427 | |
Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 8.00 | 1,000 | 8,000 | 8,605 | 9.6 K to 8.6 K (-10.41 %) |
Nov 06 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Buy | M | 3.22 | 1,000 | 3,220 | 9,605 | 8.6 K to 9.6 K (+11.62 %) |
Nov 05 2018 | BCRX | BIOCRYST PHARMACEU ... | Powell Lynne | Senior VP - CCO | Sell | S | 7.51 | 1,544 | 11,595 | 8,605 | 10.1 K to 8.6 K (-15.21 %) |